(Q36135894)

12 August 2017

Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma (English)

1 reference

12 August 2017

1 reference

Soong R

1

1 reference

12 August 2017

Knowles S

2

1 reference

12 August 2017

Williams KE

3

1 reference

12 August 2017

Hammond IG

4

1 reference

12 August 2017

Wysocki SJ

5

1 reference

12 August 2017

Iacopetta BJ

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

74

1 reference

12 August 2017

4

1 reference

12 August 2017

562-567

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1996.401

12 August 2017

0 references

cites work

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

The p53 tumour suppressor gene

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Cancer. p53, guardian of the genome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

p53 gene mutations in human endometrial carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Correlation between the conformational phenotype of p53 and its subcellular location

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

p53 expression in neoplasms of the uterine corpus.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Overexpression and mutation of p53 in endometrial carcinoma

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

P53 in tumour pathology: can we trust immunocytochemistry?

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074673

DNA synthesis-associated nuclear exclusion of p53 in normal human breast epithelial cells in culture

23 September 2018

1 reference

12 December 2020

Clinicopathological characteristics of p53 overexpression in endometrial cancers

1 reference

12 December 2020

Identification of p53 mutations by means of single strand conformation polymorphism analysis in gynaecological tumours: comparison with the results of immunohistochemistry

1 reference

12 December 2020

p53 protein and c-erbB-2 protein (p185) expression in endometrial adenocarcinoma of endometrioid type. An immunohistochemical examination on paraffin sections

1 reference

12 December 2020

Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma

1 reference

12 December 2020

Prognostic significance of p53 overexpression in endometrial cancer

1 reference

12 December 2020

Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival

1 reference

12 December 2020

Immunohistochemical analysis of p53 in gynecologic tumors

1 reference

12 December 2020

p53 status and the efficacy of cancer therapy in vivo

1 reference

12 December 2020

p53 gene mutation and expression in naevi and melanomas

1 reference

12 December 2020

Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients

1 reference

12 December 2020

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

12 December 2020

Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus

1 reference

12 December 2020

Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma

1 reference

12 December 2020

Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium

1 reference

12 December 2020

Involvement of p53 gene mutations in human endometrial carcinomas

1 reference

12 December 2020

Immunohistochemical and in situ hybridization analysis of p53 in human endometrial carcinoma of the uterus

1 reference

12 December 2020

Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status

1 reference

12 December 2020

Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.401

1 reference

OpenCitations bibliographic resource ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

8761370

1 reference